Remarkably, it has been reported that AIFM2 protects cancer cells from erastin-, sorafenib-, and RSL3-induced ferroptosis via an approach independent of ubiquinol (Bersuker et al., 2019; Doll et al., 2019). This evidence concerns the gene AIFM2 and cancer.